Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
Australians with melanoma detected before they turn 40 are more likely to have the cancer on non-sun damaged parts of the body compared to people diagnosed when older. University of Queensland...Read more
The Translational Research Institute (TRI) has awarded a research grant to fund a Phase I clinical trial for an innovative new treatment for head and neck cancer associated with Human Papillomavirus...Read more
Cancer cells gain and lose so-called ‘chromosome arms’ during tumour growth, with researchers finding these changes can help predict drug response and patient survival rates as well as...Read more
An important collaboration between researchers from the Mater Hospital, the Translational Research Institute (TRI) and the Griffith Institute for Drug Discovery (GRIDD) has led to a significant...Read more
A/Prof Jyotsna Batra wins a 2019 Queensland Young Tall Poppy Science Award Congratulations to QUT’s Associate Professor Jyotsna Batra, who has been selected as an Outstanding Early Career...Read more
The challenges of breast density in screening, detection, and prevention of breast cancer - Associate Professor Wendy Ingman Associate Professor Wendy Ingman is a breast biologist at the University...Read more
Reduced immune infiltration into nodes associated with poor outcomes in follicular lymphoma Research published today in the highly prestigious Journal of Clinical Oncology by Mater Research CEO and...Read more
Ovarian mass - cancer or benign? A non-invasive test to triage patients before surgery Researchers and clinicians at Translational Research Institute (TRI), Princess Alexandra (PA) Hospital and the...Read more
Can a patient’s own immune cells be modified to cure a rare and deadly type of lymphoma? Professor Maher Gandhi, CEO of Mater Research and Director of Mater Research Institute-UQ, is leading a...Read more
New Familial Breast Cancer Clinic NOW OPEN A new Familial Breast Cancer Clinic at the Princess Alexandra Hospital will help women with a strong family history of breast cancer better monitor and...Read more